Themes US R&D Champions ETF
USRD
0 hedge funds and large institutions have $0 invested in Themes US R&D Champions ETF in 2026 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
0.01% less ownership
Funds ownership: 0.01% → 0% (-0.01%)
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $100 → $0 (-$100)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$100 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| – | -$100 | -3 | Closed |
|
USRD Hedge Fund Activity: Q1 2026 in Review
0 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Themes US R&D Champions ETF (USRD) for Q1 2026, worth a combined $0 — down 100% from $100 a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of USRD and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was UBS Group, exiting entirely with an estimated $100 sold.
- 0 institutional investors held Themes US R&D Champions ETF (USRD) as of Q1 2026, down from 1 in Q4 2025.
- Funds reported $0 of Themes US R&D Champions ETF stock for Q1 2026, down 100% quarter-over-quarter.
- 0 funds opened new Themes US R&D Champions ETF positions in Q1 2026 and 1 closed out, a net change of -1 holder.
- The largest Themes US R&D Champions ETF seller in Q1 2026 was UBS Group, an estimated $100 sold.
Based on aggregated 13F filings for Q1 2026.